LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

LLY

1,003.75

-0.1%↓

JNJ

245.32

-0.54%↓

ABBV

235.99

+1.04%↑

NVS

165.01

+0.53%↑

AZN

201.13

+0.17%↑

Начало・Списък с акции・Schrodinger Inc

Schrodinger Inc

Затворен

СекторЗдравеопазване

13.05 4.48

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

12.41

Максимум

13.2

Ключови измерители
By Trading Economics
Приходи	169M 136M
Продажби	33M 87M
EPS	-0.18
Марж на печалбата	155.644
Служители	850
EBITDA	67M 36M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+81.07% upside

Дивиденти
By Dow Jones
Следващи печалби	6.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	69M 895M
Предишно отваряне	8.57
Предишно затваряне	13.05

Настроения в новините

By Acuity

86%

14%

330 / 351 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

23.27 / 26.13 Подкрепа & съпротива

Schrodinger Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

4.03.2026 г., 23:39 ч. UTC

Горещи акции

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4.03.2026 г., 23:20 ч. UTC

Печалби

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4.03.2026 г., 21:43 ч. UTC

Печалби

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4.03.2026 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Rise After Recent Selloffs -- Market Talk

4.03.2026 г., 23:33 ч. UTC

Пазарно говорене

Значими събития в новините

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4.03.2026 г., 23:24 ч. UTC

Пазарно говорене

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4.03.2026 г., 22:30 ч. UTC

Печалби

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4.03.2026 г., 22:30 ч. UTC

Печалби

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4.03.2026 г., 22:30 ч. UTC

Печалби

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4.03.2026 г., 22:13 ч. UTC

Печалби

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4.03.2026 г., 22:13 ч. UTC

Печалби

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4.03.2026 г., 22:13 ч. UTC

Печалби

Vermilion Energy 4Q EPS C$2.86 >VET

4.03.2026 г., 22:04 ч. UTC

Пазарно говорене

RBA Slipping Behind The Curve On Rates -- Market Talk

4.03.2026 г., 21:53 ч. UTC

Печалби

Lithium Americas 4Q Rev $66.8M >LAC

4.03.2026 г., 21:53 ч. UTC

Печалби

Lithium Americas 4Q Loss/Shr 52c >LAC

4.03.2026 г., 21:52 ч. UTC

Печалби

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4.03.2026 г., 21:50 ч. UTC

Печалби

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4.03.2026 г., 21:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

4.03.2026 г., 21:48 ч. UTC

Печалби

Webull 4Q Rev $165.2M >BULL

4.03.2026 г., 21:48 ч. UTC

Печалби

Webull 4Q EPS 1c >BULL

4.03.2026 г., 21:45 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

4.03.2026 г., 21:45 ч. UTC

Пазарно говорене

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4.03.2026 г., 21:40 ч. UTC

Печалби

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4.03.2026 г., 21:36 ч. UTC

Значими събития в новините

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4.03.2026 г., 21:27 ч. UTC

Печалби

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4.03.2026 г., 21:17 ч. UTC

Пазарно говорене

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4.03.2026 г., 21:16 ч. UTC

Печалби

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4.03.2026 г., 21:15 ч. UTC

Печалби

Broadcom 1Q EPS $1.50 >AVGO

4.03.2026 г., 21:15 ч. UTC

Печалби

Broadcom 1Q Net $7.35B >AVGO

4.03.2026 г., 21:15 ч. UTC

Печалби

Broadcom 1Q Rev $19.31B >AVGO

Сравнение с други в отрасъла

Ценова промяна

Schrodinger Inc Прогноза

Ценова цел

By TipRanks

81.07% нагоре

12-месечна прогноза

Среден 22 USD 81.07%

Висок 30 USD

Нисък 18 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Schrodinger Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на Schrodinger Inc през последните 3 месеца.

Техническа оценка

By Trading Central

23.27 / 26.13Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bullish.

Настроение

By Acuity

330 / 351 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Schrodinger Inc

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.